RaQualia Pharma Inc.
4579.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥214 | -¥350 | -¥5 | -¥155 |
| Dep. & Amort. | ¥121 | ¥119 | ¥118 | ¥123 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥171 | ¥272 | -¥475 | -¥68 |
| Other Non-Cash | -¥8 | ¥15 | ¥61 | ¥52 |
| Operating Cash Flow | ¥70 | ¥57 | -¥302 | -¥48 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥15 | -¥41 | -¥11 | ¥0 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | ¥0 | ¥0 | -¥200 | ¥0 |
| Inv. Sales/Matur. | ¥200 | ¥0 | ¥200 | ¥200 |
| Other Inv. Act. | -¥3 | -¥0 | ¥0 | -¥1 |
| Investing Cash Flow | ¥182 | -¥41 | -¥11 | ¥199 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥147 | -¥148 | -¥146 | -¥146 |
| Stock Issued | ¥0 | ¥1,019 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | -¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | ¥0 | -¥0 | -¥50 | ¥80 |
| Financing Cash Flow | -¥147 | ¥871 | -¥196 | -¥66 |
| Forex Effect | ¥16 | -¥229 | ¥132 | ¥57 |
| Net Chg. in Cash | ¥121 | ¥658 | -¥378 | ¥142 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥3,423 | ¥2,764 | ¥3,142 | ¥3,000 |
| End Cash | ¥3,543 | ¥3,423 | ¥2,764 | ¥3,142 |
| Free Cash Flow | ¥55 | ¥20 | -¥313 | -¥48 |